NEWAMSTERDAM PHARMA COMPANY NAMS
ORDINARY SHARES · Common Stock · CUSIP N62509109
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 81.6m as of 2022-12-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $13.34. Options: 1 managers hold calls ($3.8m notional), 0 hold puts (—).
Trends to Q1 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2022 | 15 |
| Q1 2023 | 20 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q2 2022 | $0 | $0 | — |
| Q3 2022 | $0 | $0 | — |
| Q4 2022 | $0 | $0 | — |
| Q1 2023 | $3.8m | $0 | 0.00 |
Biggest buyers
| VIKING GLOBAL INVESTORS LP | Added | +162.0k |
| Parkman Healthcare Partners LLC | New | +115.0k |
| GMT Capital Corp | Added | +83.8k |
| MILLENNIUM MANAGEMENT LLC | New | +55.6k |
| DEERFIELD MANAGEMENT COMPANY, L.P. | Added | +55.5k |
| Eversept Partners, LP | New | +45.9k |
| Schonfeld Strategic Advisors LLC | New | +30.1k |
| JPMORGAN CHASE & CO | Added | +21.3k |
| GEODE CAPITAL MANAGEMENT, LLC | New | +18.6k |
| WOLVERINE ASSET MANAGEMENT LLC | New | +4.8k |
Biggest sellers
| JANUS HENDERSON GROUP PLC | Sold out | -563.1k |
| Alyeska Investment Group, L.P. | Sold out | -200.0k |
| Tower Research Capital LLC (TRC) | Sold out | -88 |
Biggest calls
| Alyeska Investment Group, L.P. | New | $3.8m289.3k shares |
Biggest puts
| None |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Capital World Investors 13G · institution +1.7 pts · filed 2026-06-04 | 10.4% |
| RA CAPITAL MANAGEMENT, L.P. 13G · passive investor no change · filed 2025-05-15 | 9.9% |
| FMR LLC 13G · institution +1.2 pts · filed 2026-08-06 | 8.8% |
| Frazier Life Sciences X, L.P. 13D · may seek influence +1.0 pts · filed 2026-09-22 | 8.7% |
| Forbion Capital Fund IV Cooperatief U.A. 13D · may seek influence -1.1 pts · filed 2025-09-30 | 8.3% |
Fell to 5% or below in the last year: BCLS II Investco, LP (1.8%, 2026-05-14), VIKING GLOBAL INVESTORS LP (3.7%, 2026-02-17)
Insider purchases and sales in Q1 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q1 2023.
Holders, Q1 2023
| Manager | Shares | Change |
|---|---|---|
| Frazier Life Sciences Management, L.P. 9.09% of their portfolio | 9.3m $125.6m | Unchanged |
| Bain Capital Life Sciences Investors, LLC 13.76% of their portfolio | 8.3m $110.1m | Unchanged |
| RA CAPITAL MANAGEMENT, L.P. 1.20% of their portfolio | 4.0m $53.0m | Unchanged |
| VIKING GLOBAL INVESTORS LP 0.25% of their portfolio | 3.9m $52.6m | Added +162.0k |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.75% of their portfolio | 2.5m $33.6m | Added +55.5k |
| Medicxi Ventures Management (Jersey) Ltd 11.36% of their portfolio | 2.0m $26.5m | Unchanged |
| BVF INC/IL 0.75% of their portfolio | 1.5m $20.5m | Unchanged |
| GMT Capital Corp 0.56% of their portfolio | 1.1m $14.4m | Added +83.8k |
| Ensign Peak Advisors, Inc 0.01% of their portfolio | 355.0k $4.7m | Unchanged |
| Parkman Healthcare Partners LLC 0.33% of their portfolio | 115.0k $1.5m | New |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 55.6k $748.0k | New |
| Eversept Partners, LP 0.06% of their portfolio | 45.9k $608.1k | New |
| Schonfeld Strategic Advisors LLC 0.00% of their portfolio | 30.1k $399.1k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 22.4k $301.0k | Added +21.3k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 18.6k $249.4k | New |
| WOLVERINE ASSET MANAGEMENT LLC 0.00% of their portfolio | 4.8k $63.9k | New |
| MORGAN STANLEY 0.00% of their portfolio | 503 $6.7k | New |
| ATTICUS WEALTH MANAGEMENT, LLC 0.00% of their portfolio | 166 $2.2k | New |
| DUPONT CAPITAL MANAGEMENT CORP 0.00% of their portfolio | 1 $13 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |